-
Je něco špatně v tomto záznamu ?
Retinoic acid attenuates the mild hyperoxic lung injury in newborn mice
Magdalena Zimová-Herknerová, Jaromír Mysliveček, Petr Potměšil
Jazyk angličtina Země Česko
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- analýza rozptylu MeSH
- antioxidancia farmakologie MeSH
- genetická transkripce účinky záření MeSH
- glyceraldehyd-3-fosfátdehydrogenasy metabolismus účinky léků MeSH
- hyperoxie komplikace metabolismus patologie MeSH
- messenger RNA analýza MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- novorozená zvířata MeSH
- plicní alveoly metabolismus patologie růst a vývoj účinky léků MeSH
- plicní nemoci etiologie metabolismus patologie prevence a kontrola MeSH
- stupeň závažnosti nemoci MeSH
- tretinoin farmakologie MeSH
- vaskulární endoteliální růstový faktor A genetika metabolismus účinky léků MeSH
- vývojová regulace genové exprese účinky léků MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
Neonatal exposure to hyperoxia alters lung development in mice. We tested if retinoic acid (RA) treatment is capable to affect lung development after hyperoxic injury and to maintain structural integrity of lung. The gene of vascular endothelial growth factor A (VEGF-A) is one of the RA-responsive genes. Newborn BALB/c mice were exposed to room air, 40% or 80% hyperoxia for 7 days. One half of animals in each group received 500 mg/kg retinoic acid from day 3 to day 7 of the experiment. At the end of experiment we assessed body weight (BW), lung wet weight (LW), the wet-to-dry lung weight ratio (W/D) and the expression of mRNA for VEGF-A and G3PDH genes. On day 7 the hyperoxia-exposed sham-treated mice (group 80) weighed 20% less than the room air-exposed group, whereas the 80% hyperoxic group treated with RA weighed only 13% less than the normoxic group. W/D values in 80 and 80A groups did not differ, although they both differed from the control group and from 40 groups. There was a significant difference between 40 and 40A groups, but the control group was different from 40 group but not from 40A groups. The 80 and 80A groups had mRNA VEGF-A expression lowered to 64% and 41% of the control group. RA treatment of normoxic and mild hyperoxic groups increased mRNA VEGF-A expression by about 50%. We conclude that the retinoic acid treatment of newborn BALB/c mice exposed for 7 days to 80% hyperoxia reduced the growth retardation in the 80 % hyperoxic group, reduced the W/D ratio in the 40% but not in the 80 % hyperoxic group. Higher VEGF-A mRNA expression in the 80% hyperoxic group treated with RA was not significant compared to the 80% hyperoxic group.
Citace poskytuje Crossref.org
Lit.: 21
- 000
- 04116naa 2200517 a 4500
- 001
- bmc07511521
- 003
- CZ-PrNML
- 005
- 20120813105600.0
- 008
- 081031s2008 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.930794 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Herknerová, Madgalena $7 xx0093426
- 245 10
- $a Retinoic acid attenuates the mild hyperoxic lung injury in newborn mice / $c Magdalena Zimová-Herknerová, Jaromír Mysliveček, Petr Potměšil
- 314 __
- $a Neonatological Department of General Faculty Hospital, Prague
- 504 __
- $a Lit.: 21
- 520 9_
- $a Neonatal exposure to hyperoxia alters lung development in mice. We tested if retinoic acid (RA) treatment is capable to affect lung development after hyperoxic injury and to maintain structural integrity of lung. The gene of vascular endothelial growth factor A (VEGF-A) is one of the RA-responsive genes. Newborn BALB/c mice were exposed to room air, 40% or 80% hyperoxia for 7 days. One half of animals in each group received 500 mg/kg retinoic acid from day 3 to day 7 of the experiment. At the end of experiment we assessed body weight (BW), lung wet weight (LW), the wet-to-dry lung weight ratio (W/D) and the expression of mRNA for VEGF-A and G3PDH genes. On day 7 the hyperoxia-exposed sham-treated mice (group 80) weighed 20% less than the room air-exposed group, whereas the 80% hyperoxic group treated with RA weighed only 13% less than the normoxic group. W/D values in 80 and 80A groups did not differ, although they both differed from the control group and from 40 groups. There was a significant difference between 40 and 40A groups, but the control group was different from 40 group but not from 40A groups. The 80 and 80A groups had mRNA VEGF-A expression lowered to 64% and 41% of the control group. RA treatment of normoxic and mild hyperoxic groups increased mRNA VEGF-A expression by about 50%. We conclude that the retinoic acid treatment of newborn BALB/c mice exposed for 7 days to 80% hyperoxia reduced the growth retardation in the 80 % hyperoxic group, reduced the W/D ratio in the 40% but not in the 80 % hyperoxic group. Higher VEGF-A mRNA expression in the 80% hyperoxic group treated with RA was not significant compared to the 80% hyperoxic group.
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a vývojová regulace genové exprese $x účinky léků $7 D018507
- 650 _2
- $a glyceraldehyd-3-fosfátdehydrogenasy $x metabolismus $x účinky léků $7 D005987
- 650 _2
- $a hyperoxie $x komplikace $x metabolismus $x patologie $7 D018496
- 650 _2
- $a plicní nemoci $x etiologie $x metabolismus $x patologie $x prevence a kontrola $7 D008171
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a plicní alveoly $x metabolismus $x patologie $x růst a vývoj $x účinky léků $7 D011650
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a genetická transkripce $x účinky záření $7 D014158
- 650 _2
- $a tretinoin $x farmakologie $7 D014212
- 650 _2
- $a vaskulární endoteliální růstový faktor A $x genetika $x metabolismus $x účinky léků $7 D042461
- 700 1_
- $a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583
- 700 1_
- $a Potměšil, Petr $7 xx0102562
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 57, č. 1 (2008), s. 33-40 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/57/57_33.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 1
- 990 __
- $a 20081030145146 $b ABA008
- 991 __
- $a 20120813105649 $b ABA008
- 999 __
- $a ok $b bmc $g 627111 $s 479547
- BAS __
- $a 3
- BMC __
- $a 2008 $b 57 $c 1 $d 33-40 $i 0862-8408 $m Physiological research $x MED00003824
- LZP __
- $a 2008-19/mkme